Beiersdorf (BEI) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Achieved record net sales of €9.9 billion in 2024, with organic sales growth of 6.5% at group level and EBIT margin (excluding special factors) up 50 bps to 13.9%.
Consumer segment, led by Nivea and derma brands (Eucerin, Aquaphor), outperformed the market.
Innovation, expansion into new markets (India, China, USA), and sustainability initiatives were key strategic pillars.
Advanced diversity, equity, and inclusion (DE&I) and climate action, including significant CO2 reduction and gender pay equity.
Positioned for ongoing success in 2025 and beyond, with continued focus on innovation and sustainability.
Financial highlights
Group organic sales growth of 6.5% and nominal growth of 4.3% year-over-year.
EBIT reached €1.4 billion (excluding special factors), profit after tax at €928 million.
Earnings per share rose from €3.24 to €4.05.
Consumer segment organic sales up 7.5% to €8,162m; Tesa segment up 1.9% to €1,688m.
Gross margin improved by 120 bps, with Consumer gross margin at 60.6%.
Outlook and guidance
2025 group organic sales growth expected at 4%-6%, with Consumer segment at 4%-6% and Tesa at 1%-3%.
EBIT margin (excluding special factors) projected to rise by 50 bps in Consumer and reach ~16% in Tesa.
Q1 2025 expected below full-year range due to strong prior-year comparison and China inventory cleanup.
Continued focus on innovation, market expansion, and disciplined cost management.
Latest events from Beiersdorf
- Q1 2025 organic sales up 3.6%, with robust Derma and tesa growth; guidance reaffirmed.BEI
Q1 20258 Jul 2026 - AGM approved all proposals, focusing on NIVEA's strategy, innovation, and shareholder returns.BEI
AGM 202627 Apr 2026 - Q1 2026 organic sales fell 4.6%, but Derma growth and NIVEA rebalancing support optimism.BEI
Q1 202626 Apr 2026 - Solid 2025 growth driven by Derma, with flat outlook and margin pressure expected in 2026.BEI
Q4 202525 Apr 2026 - 7.1% organic sales growth, margin expansion, and guidance reaffirmed despite market headwinds.BEI
Q2 20242 Feb 2026 - Strong 6.5% organic sales growth led by NIVEA and Derma; guidance for 6–8% reaffirmed.BEI
Q3 202419 Jan 2026 - Organic sales rose 2.0% to €7.5B, led by Derma, as guidance was trimmed amid market slowdown.BEI
Q3 20253 Dec 2025 - Organic sales up 2.1% in H1 2025, with stable margins and strong Derma growth.BEI
Q2 202523 Nov 2025 - Accelerated growth, innovation, and sustainability drive Beiersdorf’s leadership in global skin care.BEI
CMD 2024 Presentation13 Jun 2025